GF Fund Management CO. LTD. Makes New $38.80 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GF Fund Management CO. LTD. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 74,331 shares of the medical equipment provider's stock, valued at approximately $38,798,000. Intuitive Surgical accounts for approximately 0.8% of GF Fund Management CO. LTD.'s holdings, making the stock its 20th largest position.

Several other hedge funds have also made changes to their positions in ISRG. Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock valued at $635,000 after buying an additional 19 shares during the period. Raleigh Capital Management Inc. lifted its stake in Intuitive Surgical by 8.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 318 shares of the medical equipment provider's stock worth $166,000 after purchasing an additional 24 shares during the period. Galvin Gaustad & Stein LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $218,000. FCG Investment Co lifted its stake in Intuitive Surgical by 9.9% during the fourth quarter. FCG Investment Co now owns 2,362 shares of the medical equipment provider's stock worth $1,233,000 after purchasing an additional 212 shares during the period. Finally, Conway Capital Management Inc. lifted its stake in Intuitive Surgical by 8.4% during the fourth quarter. Conway Capital Management Inc. now owns 4,951 shares of the medical equipment provider's stock worth $2,584,000 after purchasing an additional 382 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

ISRG traded up $10.65 during trading on Tuesday, reaching $550.19. 1,243,739 shares of the company's stock were exchanged, compared to its average volume of 1,645,228. The company's fifty day moving average price is $512.50 and its 200-day moving average price is $538.12. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00. The firm has a market capitalization of $197.20 billion, a PE ratio of 85.83, a P/E/G ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the business's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 2,401 shares of the business's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares of the company's stock, valued at $205,093. This trade represents a 87.18% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock valued at $16,865,621 in the last quarter. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Citigroup restated a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Barclays cut their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Finally, Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research note on Monday, January 27th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.